Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review

Am J Clin Pathol. 2005 May;123(5):662-75.

Abstract

Blastic natural killer (NK) cell lymphoma (also termed CD4+CD56+ hematodermic neoplasm) is a recently described entity, with the first case reported in 1994. It was suggested initially that the disease originates from NK cells. Since 1994, single cases and a few small series have been published. In this review, data from the literature and a series of 30 cases from the French and Dutch study groups on cutaneous lymphomas are discussed. The major clinical, histopathologic, and phenotypic aspects of the disease and diagnostic criteria and data suggesting a plasmacytoid dendritic cell origin for the tumor cells are provided.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Neoplasm / metabolism*
  • Biomarkers, Tumor / metabolism
  • CD4 Antigens / metabolism*
  • CD4-Positive T-Lymphocytes / metabolism
  • CD4-Positive T-Lymphocytes / pathology
  • CD56 Antigen / metabolism*
  • Child
  • Dendritic Cells / metabolism
  • Dendritic Cells / pathology
  • Female
  • Humans
  • Killer Cells, Natural / metabolism
  • Killer Cells, Natural / pathology*
  • Lymphoma, Non-Hodgkin / metabolism
  • Lymphoma, Non-Hodgkin / pathology*
  • Male
  • Middle Aged
  • Plasma Cells / metabolism
  • Plasma Cells / pathology
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / pathology*

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • CD4 Antigens
  • CD56 Antigen